Practical Concepts and Defining Failure to First-line MF Treatment
Download this slideset from a live symposium at ASCO 2023 to review expert perspectives on practical considerations with treatment for patients with myelofibrosis, including symptom and anemia management and determination of suboptimal response or failure with JAK inhibitors.
President Enterprise Cancer Service Line Executive Director Atrium Health Wake Forest Baptist Comprehensive Cancer Center Enterprise Senior Vice President Atrium Health Vice Dean for Cancer Programs Wake Forest University School of Medicine Professor of Medicine Wake Forest University School of Medicine Winston-Salem, North Carolina
Provided by Clinical Care Options, LLC
Supported by educational grants from AbbVie, Inc., CTI BioPharma, GSK, and Incyte Corporation.
Select date of attendance
Welcome to the CCO site
Thank you for your interest in CCO content. As a guest, please complete the following information. This data helps ensure our continued delivery of impactful medical education.
You will be sent to the previous page if you close this window.